Concert: Markets: Sun Pharma makes $576m offer to takeover Concert of Lexington

Sun Pharma is building a global Dermatology and Ophthalmology franchise, says Gandhi Sun Pharmaceutical Industries Limited (Reuters: SUN.BO) (Bloomberg: SUNP IN) (NSE: SUNPHARMA) (BSE: 524715) has made an offer of US$576 million in equity value to acquire Lexington, Massachusetts' Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) for building a global Dermatology and Ophthalmology franchise. Sun Pharma will [...]